|
Market Closed -
Nasdaq
16:00:00 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 80.38 USD | +0.17% |
|
+1.15% | -0.89% |
| 08-06 | Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95 | MT |
| 08-05 | Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform | MT |
Company Valuation: LeMaitre Vascular, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,097 | 1,012 | 1,264 | 2,072 | 1,840 | 1,838 | - | - |
| Change | - | -7.7% | 24.81% | 63.94% | -11.19% | -0.09% | - | - |
| Enterprise Value (EV) 1 | 1,097 | 1,012 | 1,264 | 2,072 | 1,840 | 1,598 | 1,538 | 1,838 |
| Change | - | -7.7% | 24.81% | 63.94% | -11.19% | -13.16% | -3.75% | 19.53% |
| P/E | 40.2x | 49.5x | 42.4x | 47.7x | 32.2x | 28x | 25.3x | 23.2x |
| PBR | - | - | - | - | - | 4.19x | 3.62x | - |
| PEG | - | -1.9x | 1x | 1.1x | 1.1x | 2x | 2.4x | 2.6x |
| Capitalization / Revenue | 7.1x | 6.26x | 6.53x | 9.42x | 7.37x | 6.65x | 6.07x | 5.61x |
| EV / Revenue | 7.1x | 6.26x | 6.53x | 9.42x | 7.37x | 5.78x | 5.08x | 5.61x |
| EV / EBITDA | 24x | 25.9x | 27.5x | 33.6x | 24.8x | 18.3x | 15.7x | 17.1x |
| EV / EBIT | 30.1x | 33.8x | 34.4x | 39.6x | 27.1x | 20.7x | 17.6x | 19.1x |
| EV / FCF | 36.3x | 45.7x | 42.9x | 55.7x | 24.7x | 25.6x | 19.6x | 22.5x |
| FCF Yield | 2.75% | 2.19% | 2.33% | 1.79% | 4.05% | 3.9% | 5.09% | 4.45% |
| Dividend per Share 2 | 0.44 | 0.5 | 0.56 | 0.64 | 0.8 | 1 | 1.12 | - |
| Rate of return | 0.88% | 1.09% | 0.99% | 0.69% | 0.99% | 1.24% | 1.39% | - |
| EPS 2 | 1.25 | 0.93 | 1.34 | 1.93 | 2.52 | 2.872 | 3.179 | 3.462 |
| Distribution rate | 35.2% | 53.8% | 41.8% | 33.2% | 31.7% | 34.8% | 35.2% | - |
| Net sales 1 | 154.4 | 161.7 | 193.5 | 219.9 | 249.6 | 276.5 | 302.9 | 327.5 |
| EBITDA 1 | 45.78 | 39.04 | 45.91 | 61.74 | 74.31 | 87.25 | 97.82 | 107.4 |
| EBIT 1 | 36.42 | 29.94 | 36.71 | 52.26 | 67.91 | 77.29 | 87.27 | 96.37 |
| Net income 1 | 26.91 | 20.64 | 30.1 | 44.04 | 57.73 | 66.71 | 74.29 | 81.8 |
| Net Debt 1 | - | - | - | - | - | -240.5 | -300.4 | - |
| Reference price 2 | 50.23 | 46.02 | 56.76 | 92.14 | 81.10 | 80.38 | 80.38 | 80.38 |
| Nbr of stocks (in thousands) | 21,838 | 22,001 | 22,263 | 22,484 | 22,686 | 22,869 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 2/27/24 | 2/27/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.93x | 5.77x | 18.28x | 1.25% | 1.84B | |
| 31.87x | 5.6x | 21.46x | 0.29% | 237B | |
| 35.31x | 6.37x | 20.19x | 0.67% | 147B | |
| 40.87x | 10.77x | 23.79x | -.--% | 133B | |
| 16.55x | 3.39x | 11.05x | -.--% | 63.58B | |
| 19.31x | 2.32x | 11.66x | 2.64% | 49.95B | |
| 33.88x | 6.77x | 21.43x | -.--% | 49.42B | |
| 29.27x | 5.81x | 19.73x | 0.68% | 42.37B | |
| 73.02x | 6.96x | 21.22x | -.--% | 40.98B | |
| 44.94x | 7.23x | 25.54x | -.--% | 33.57B | |
| Average | 35.30x | 6.10x | 19.43x | 0.55% | 79.93B | |
| Weighted average by Cap. | 34.64x | 6.45x | 20.23x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- LMAT Stock
- Valuation LeMaitre Vascular, Inc.
Select your edition
All financial news and data tailored to specific country editions
